Jointown Pharmaceutical Group Co Ltd Net Asset Momentum
Jointown Pharmaceutical Group Co Ltd net asset momentum. Jointown Pharmaceutical Group Co Ltd (600998) recorded a net asset momentum of 14.0% as of December 2024, with net assets of CN¥33.59 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Jointown Pharmaceutical Group Co Ltd (600998) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Jointown Pharmaceutical Group Co Ltd (2007–2024)
Net asset momentum of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. This chart tracks Jointown Pharmaceutical Group Co Ltd's year-over-year net asset growth across 18 annual reporting periods from 2007 to 2024. The most recent momentum reading is +14.0%, with net assets of CN¥33.59 Billion CNY as of December 2024. Check 600998 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Jointown Pharmaceutical Group Co Ltd Net Asset Momentum by Year (2007–2024)
Jointown Pharmaceutical Group Co Ltd net asset momentum by year from 2007 to 2024. The table below shows the complete annual net asset history for Jointown Pharmaceutical Group Co Ltd from 2007 to 2024, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Jointown Pharmaceutical Group Co Ltd market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥33.59 Billion | CN¥102.40 Billion | CN¥68.80 Billion | ▲ +14.0% |
| 2023 | CN¥29.48 Billion | CN¥92.79 Billion | CN¥63.31 Billion | ▲ +2.8% |
| 2022 | CN¥28.69 Billion | CN¥92.27 Billion | CN¥63.59 Billion | ▲ +6.0% |
| 2021 | CN¥27.07 Billion | CN¥85.94 Billion | CN¥58.86 Billion | ▲ +5.7% |
| 2020 | CN¥25.62 Billion | CN¥80.82 Billion | CN¥55.21 Billion | ▲ +16.6% |
| 2019 | CN¥21.97 Billion | CN¥71.15 Billion | CN¥49.18 Billion | ▲ +7.8% |
| 2018 | CN¥20.38 Billion | CN¥66.67 Billion | CN¥46.29 Billion | ▲ +4.3% |
| 2017 | CN¥19.54 Billion | CN¥52.05 Billion | CN¥32.51 Billion | ▲ +62.7% |
| 2016 | CN¥12.01 Billion | CN¥38.73 Billion | CN¥26.72 Billion | ▲ +22.0% |
| 2015 | CN¥9.85 Billion | CN¥32.58 Billion | CN¥22.74 Billion | ▲ +21.7% |
| 2014 | CN¥8.09 Billion | CN¥24.13 Billion | CN¥16.04 Billion | ▲ +51.5% |
| 2013 | CN¥5.34 Billion | CN¥18.60 Billion | CN¥13.26 Billion | ▲ +10.4% |
| 2012 | CN¥4.84 Billion | CN¥14.80 Billion | CN¥9.97 Billion | ▲ +12.4% |
| 2011 | CN¥4.30 Billion | CN¥11.84 Billion | CN¥7.54 Billion | ▲ +7.6% |
| 2010 | CN¥4.00 Billion | CN¥8.12 Billion | CN¥4.12 Billion | ▲ +139.1% |
| 2009 | CN¥1.67 Billion | CN¥7.17 Billion | CN¥5.50 Billion | ▲ +13.2% |
| 2008 | CN¥1.48 Billion | CN¥5.72 Billion | CN¥4.24 Billion | ▲ +15.3% |
| 2007 | CN¥1.28 Billion | CN¥4.42 Billion | CN¥3.14 Billion | — |